Am J Pathology | Am J Pathology Triple-negative breast cancer is viewed clinically as an aggressive subgroup of breast cancer. In fact, most triple-negative breast cancers are poor-prognosis tumors with a complex genomic landscape. However, triple-negative disease is vastly ... |
Feeds
2546 items (2546 unread) in 74 feeds
Acinar Cell Carcinoma
(12 unread)
Acinic Cell Carcinoma
(15 unread)
Adenoid Cystic Carcinoma
(43 unread)
Adrenal Gland Cancer
(166 unread)
Ampulla Of Vater
(16 unread)
Anal Cancer
(215 unread)
Angiosarcoma
(49 unread)
Appendix Cancer
(34 unread)
Bile Duct Cancer
(320 unread)
Brain and CNS
(329 unread)
Carcinoid
(47 unread)
Endocrine/Neuroendocrine
(349 unread)
Gall Bladder Cancer
(71 unread)
Hemangioendothelioma
(22 unread)
Hepatoblastoma
(20 unread)
Pancreas
(26 unread)
Phyllodes
(11 unread)
PMP and Mucinous Tumors
(13 unread)
Rhabdomyosarcoma
(62 unread)
Sarcoma
(726 unread)
Google - Acinic Cell Carcinoma (2 unread)
-
The Spectrum of Triple-Negative Breast Disease - Am J Pathology
Posted: July 21st, 2017, 10:03pm GMT
-
Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype - Nature.com
Posted: August 20th, 2015, 7:27am GMT
Nature.comDuctal activation of oncogenic KRAS alone induces sarcomatoid phenotype
Nature.com
Diegel, C. R., Cho, K. R., El-Naggar, A. K., Williams, B. O. & Lindvall, C. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma ...